HPE Europe 2020: What Impact has Coronavirus had on Doing Healthcare Deals? | McDermott Skip to main content

HPE Europe 2020: What Impact has Coronavirus had on Doing Healthcare Deals?

HPE Europe 2020: What Impact has Coronavirus had on Doing Healthcare Deals?

Overview



The evolving European healthcare market continues to drive investment activity to record levels, however is the timing of deals being impacted by the pandemic? We hope you can join us for our fifth webinar in the HPE Europe 2020 series, where we will explore the healthcare transactional landscape in depth in our post-COVID world.

Our panel of industry experts will address a range of issues facing healthcare investors, exploring key considerations for the savvy investor in today’s market including:

  • Have prices been impacted for healthcare assets?
  • How do investment strategies differ by health sub-sector?
  • Is a one-off impact with a V-shaped recovery expected following the pandemic?
  • What regulatory impact or changes are expected as a result of COVID-19 and how will these changes affect the deal landscape?

To learn more about this series click here.

Registration

3 pm – 4 pm BST

Dig Deeper

London / In-person / September 24, 2026

HPE Europe 2026

Brussels, Belgium / Speaking Engagements / May 21, 2026

EU Pharmaceutical Law Forum 2026

Nashville, TN / In-person / May 20 - 21, 2026

McDermott HealthEx 2026

San Francisco, CA / In-person / April 30, 2026

Health Tech Investment Forum 2026

Orlando, FL / Speaking Engagements / April 23 – 24, 2026

NAMCP 2026 Spring Managed Care Forum

New York, NY / Speaking Engagements / March 25 – 26, 2026

ACI’s FDA Boot Camp